PON-1 haplotype (-108C>T, L55M, and Q192R) modulates the serum levels and activity PONase promoting an atherogenic lipid profile in rheumatoid arthritis patients
Oscar Zaragoza-García,Iris Paola Guzmán-Guzmán,Ma. Elena Moreno-Godínez,José Eduardo Navarro-Zarza,Verónica Antonio-Vejar,Mónica Ramírez,Isela Parra-Rojas
DOI: https://doi.org/10.1007/s10067-020-05218-w
2020-06-18
Clinical Rheumatology
Abstract:Paraoxonase 1 (PON1) promotes antioxidant and antiatherogenic activity related to the hydrolysis of oxidized lipids of low-density lipoproteins. In rheumatoid arthritis (RA) patients, it has been reported that low PON1 activity is related to an impaired lipid profile, increasing cardiovascular risk (CVR). The goal of this study was to analyze the effect of common PON1 polymorphisms and haplotypes on enzymatic activity, PON1 serum levels (PON1s), and lipid parameters related to atherogenic profile in RA patients.
rheumatology
What problem does this paper attempt to address?